Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000161931 | SCV000211915 | benign | Gorlin syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697056 | SCV000535221 | likely benign | not provided | 2020-08-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variant in a gene in which most reported pathogenic variants are truncating/loss-of-function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV000569148 | SCV000674458 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001697056 | SCV004219190 | benign | not provided | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697056 | SCV005890294 | likely benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | PTCH1: BS1 |
Prevention |
RCV004551375 | SCV004751237 | likely benign | PTCH1-related disorder | 2019-11-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |